Monoclonal antibody ICR-62
Latest Information Update: 26 Nov 2007
At a glance
- Originator Royal Marsden Hospital; The Institute of Cancer Research
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer